These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1620838)

  • 1. Nonpalpable, probably benign lesions: role of follow-up mammography.
    Varas X; Leborgne F; Leborgne JH
    Radiology; 1992 Aug; 184(2):409-14. PubMed ID: 1620838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases.
    Sickles EA
    Radiology; 1991 May; 179(2):463-8. PubMed ID: 2014293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography.
    Vizcaíno I; Gadea L; Andreo L; Salas D; Ruiz-Perales F; Cuevas D; Herranz C; Bueno F;
    Radiology; 2001 May; 219(2):475-83. PubMed ID: 11323475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonography as adjunct to mammography in the evaluation of breast tumors.
    Skaane P
    Acta Radiol Suppl; 1999; 420():1-47. PubMed ID: 10693544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient.
    Sickles EA
    Radiology; 1994 Aug; 192(2):439-42. PubMed ID: 8029411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of mammography to reveal nonpalpable breast cancer in women with palpable breast masses.
    Rosen EL; Sickles E; Keating D
    AJR Am J Roentgenol; 1999 Feb; 172(2):309-12. PubMed ID: 9930773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
    Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
    AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
    Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
    Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?
    Graf O; Helbich TH; Fuchsjaeger MH; Hopf G; Morgun M; Graf C; Mallek R; Sickles EA
    Radiology; 2004 Dec; 233(3):850-6. PubMed ID: 15486217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stereotaxic cytologic examination of non-palpable lesions of the breast. Experience with 791 consecutive cases].
    Ciatto S; Rosselli del Turco M; Bravetti P; Catarzi S
    Radiol Med; 1991; 81(1-2):65-8. PubMed ID: 2006339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of roentgenologic characteristics and risk factors for nonpalpable carcinoma of the breast.
    Harkins K; Tartter PI; Hermann G; Squitieri R; Brower ST; Keller RJ
    J Am Coll Surg; 1994 Feb; 178(2):149-54. PubMed ID: 8173725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women.
    Harvey JA; Nicholson BT; Lorusso AP; Cohen MA; Bovbjerg VE
    AJR Am J Roentgenol; 2009 Dec; 193(6):1723-30. PubMed ID: 19933671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wire-guided biopsies of nonpalpable breast lesions.
    Ahovuo J; Kinnunen J; von Smitten K; Edgren J
    Ann Chir Gynaecol; 1990; 79(2):82-4. PubMed ID: 2386362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiology of nonpalpable breast lesions].
    Vega A; Nava E; Ortega E; Garijo F
    Rev Med Univ Navarra; 1995; 39(4):11-7. PubMed ID: 9499837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy?
    Graf O; Helbich TH; Hopf G; Graf C; Sickles EA
    Radiology; 2007 Jul; 244(1):87-93. PubMed ID: 17581897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer in nonpalpable lesions: can mammographic parenchymal pattern improve the predictive value of biopsy?
    Weaver M
    Am Surg; 1992 Nov; 58(11):692-4. PubMed ID: 1485702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of mammographic indeterminate lesions. First place winner of the Conrad Jobst Award in the Gold Medal paper competition.
    Hamby LS; McGrath PC; Stelling CB; Baker KF; Sloan DA; Kenady DE
    Am Surg; 1993 Jan; 59(1):4-8. PubMed ID: 8386912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).
    Gruber R; Jaromi S; Rudas M; Pfarl G; Riedl CC; Flöry D; Graf O; Sickles EA; Helbich TH
    Eur J Radiol; 2013 Mar; 82(3):398-403. PubMed ID: 22429299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpalpable, probably benign breast lesions in general practice: the role of follow-up mammography.
    Duijm LE; Zaat JO; Guit GL
    Br J Gen Pract; 1998 Jul; 48(432):1421-3. PubMed ID: 9800404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography-guided stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: prospective comparison with surgical biopsy results.
    Fajardo LL; Davis JR; Wiens JL; Trego DC
    AJR Am J Roentgenol; 1990 Nov; 155(5):977-81. PubMed ID: 2120967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.